Cereact (arundic acid) / Ono Pharma 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cereact (arundic acid) / Ono Pharma
2004-002912-27: Open-Label Extension Study to Investigate the Continued Safety and Effect of ONO 2506PO (1200 mg OD).

Ongoing
2
24
Europe
ONO-2506PO, ONO-2506PO,
ONO PHARMA UK LTD
Amyotrophic lateral sclerosis
 
 

Download Options